Awards & Advancement

BioDelivery Sciences names Adrian Hepner vice president

Tuesday, July 30, 2013 12:00 PM

Pharmaceutical company BioDelivery Sciences International (BDSI), headquartered in Raleigh, N.C., has hired Adrian Hepner, M.D., Ph.D., as vice president of clinical research and regulatory affairs. Hepner joins BDSI with over 20 years of experience in U.S. and international clinical research and drug development, including development and implementation of the clinical and regulatory strategy for a number of products from early stage development through NDA and E.U. regulatory filings.

More... »

Trevor Jones appointed chairman of Simbec Research

Tuesday, July 30, 2013 11:00 AM

CRO Simbec Research has appointed professor Trevor M. Jones  non-executive chairman of the board of directors. Jones was formerly group R&D director of Wellcome and director general of the Association of the British Pharmaceutical Industry (ABPI).

More... »

Saint Luke's Cancer Institute appoints new medical director

Friday, July 26, 2013 03:13 PM

Saint Luke's Cancer Institute (SLCI) has appointed Timothy J. Pluard, M.D., medical director. Pluard is associate professor of medicine at Washington University and clinical director, section of breast oncology at Siteman Cancer Center, a National Cancer Institute (NCI) designated Comprehensive Cancer Center, at Washington University/Barnes Jewish Hospital in Saint Louis, Mo.

More... »

Gentris names Amelia Wall president

Friday, July 26, 2013 03:12 PM

Gentris, a pharmacogenomics and biorepository solutions company, has named Dr. Amelia Wall Warner its new president. Warner will oversee U.S. operations, lead the development of new service offerings and develop scientific education and training programs for biobanking and pharmacogenomics.

More... »

Aptuit names Maurizio Denaro general manager

Friday, July 26, 2013 03:10 PM

Global pharmaceutical company Aptuit has appointed Dr. Maurizio Denaro general manager of The Aptuit Center for Discovery & Development in Verona, Italy.

More... »

Chiltern names Andrew Monaghan director, global pharmacovigilance

Friday, July 26, 2013 03:07 PM

Global CRO Chiltern International has appointed Andrew Monaghan, Ph.D., director, global pharmacovigilance. Monaghan will lead the pharmacovigilance team and expand the company’s pharmacovigilance offering.

More... »

Rho hires vice president of operations

Wednesday, July 24, 2013 09:45 AM

CRO Rho has appointed Richard Koenig vice president of operations. Koenig has close to 30 years of operations management and clinical development experience, most recently as vice president of operations for ClinStar.

More... »

Frontage Laboratories names new head of global CMC services

Wednesday, July 24, 2013 09:43 AM

Frontage Laboratories has appointed Dr. Cheryl Li senior vice president, Global CMC Services.  The division offers an integrated service portfolio ranging from dosage form product development, contract manufacturing, pharmaceutical analysis and organic syntheses to CMC strategy consulting. Li’s position is an initial step of Frontage’s corporate strategic expansion in CMC infrastructure to meet growing development needs in novel drugs, generic products and biosimilars.

More... »

Oligomerix names senior director of chemistry

Wednesday, July 24, 2013 09:21 AM

Oligomerix, a privately held company focused on the discovery and development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, has appointed James Hendrix, Ph.D., senior director of chemistry.

More... »

Frontage Laboratories makes two senior appointments

Thursday, July 18, 2013 10:30 AM

George Laskaris and Alma Villasin have joined Frontage Laboratories in senior positions. Laskaris has been named senior director, Frontage Biometrics Services, and Villasin, R.N., B.S.N., M.B.A., joins as director, clinical operations.

More... »